Gene and molecular-level interventions are just one example of how modern medicine is seeking to push boundaries and uncover breakthroughs. CRISPR-Cas9 is the most common gene-editing technology used today. The Cleveland Clinic conducted a Phase 1, first-in-human clinical trial overseas to test the safety and effectiveness of a new CRISPR-Cas9 gene-editing therapy called CTX310. While a relatively new biotech startup, called Preventive, announced its plans to pursue embryo-editing technologies aimed at preventing hereditary disease, and preparing for the possibility of implanting a genetically edited embryo to create a baby. Many uncertainties surround gene editing practices, leaving professionals unsure of how far such technologies should go and how they should be regulated.
View More Build-A-Baby: Is Gene Editing the Future of Humanity?
